Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Abstract Background Previous studies have confirmed that systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) can predict the prognosis and chemotherapy efficacy of various malignant tumors. However, to the best of our knowledge, no study investigated the SII combined with...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ping’an Ding, Honghai Guo, Chenyu Sun, Peigang Yang, Na Hyun Kim, Yuan Tian, Yang Liu, Pengpeng Liu, Yong Li, Qun Zhao
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2022-03-01
Series:	BMC Gastroenterology
Assuntos:	Systemic immune-inflammatory index (SII) Prognostic nutritional index (PNI) Chemosensitivity Immunotherapy Locally advanced gastric cancer
Acceso en liña:	https://doi.org/10.1186/s12876-022-02199-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!